Ample investigations have shown that genetic ablation of Nrf2 worsens the inflammation and increases the oxidative stress in numerous disease models, including pulmonary fibrosis (50), sepsis (51), acute lung injury (52), COPD exacerbations (53), and emphysema (54). This evidence concerns the gene NFE2L2 and pulmonary emphysema.